SEC Tracker
Get the app

Organon OGN

Organon names Cox as Executive Chair with $100,000 monthly salary

Item 5.02 Executive or director change

Form
8-K/A
Filed
Importance
Notable
  1. Ms. Cox appointed Executive Chair
  2. Monthly base salary of $100,000
  3. Talent Committee approved compensation

Written from the 8-K/A on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Organon files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Cytokinetics CYTK public float $2.5B, Jun 30, 2025
  2. TG Therapeutics TGTX public float $2.5B, Jun 30, 2025
  3. Catalyst Pharmaceuticals CPRX public float $2.5B, Jun 30, 2025
  4. Summit Therapeutics SMMT public float $2.5B, Jun 30, 2025
  5. Xenon Pharmaceuticals XENE public float $2.4B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.